Racial/Ethnic Disparities in Lost Earnings From Cancer Deaths in the United States
AbstractBackground. Little is known about disparities in economic burden due to premature cancer deaths by race or ethnicity in the United States. This study a
AbstractBackground. Little is known about disparities in economic burden due to premature cancer deaths by race or ethnicity in the United States. This study a
AbstractBackground. Vaccination against human papillomavirus (HPV) is critical to the prevention of HPV-associated cancers. This study aimed to describe th
AbstractBackground. Osimertinib is the first-line therapy for patients with non-small cell lung cancer harboring epidermal growth factor receptor–activatin
Abstract. Individuals diagnosed with cancer are a vulnerable population during disasters. Emergency preparedness efforts are crucial for meeting the health
AbstractBackground. Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.Methods. Using its networking and shar
AbstractBackground. Cancer patients’ attitudes toward progression-free survival (PFS) gains offered by treatment are not well understood, particularly in t
AbstractBackground. The widespread introduction of Pap testing in the 1960s was followed by substantial reductions in the incidence of cervical squamous ce
AbstractBackground. Breast cancer survivors have increased incidence of age-related diseases, suggesting that some survivors may experience faster biologic
Abstract. Generally, risk stratification models for cancer use effect estimates from risk/protective factor analyses that have not assessed potential inter
AbstractBackground. Recently, several new treatment regimens have been approved for treating metastatic hormone-sensitive prostate cancer, building on andr
AbstractBackground. Prostate cancer (PC) survivors may potentially use substances to cope with psychological distress or poorly controlled physical symptom